p53: a two-faced cancer gene
- 1 May 2007
- journal article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 9 (5), 489-491
- https://doi.org/10.1038/ncb0507-489
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Mutant p53 Enhances Nuclear Factor κB Activation by Tumor Necrosis Factor α in Cancer CellsCancer Research, 2007
- p53-R273H gains new function in induction of drug resistance through down-regulation of procaspase-3Molecular Cancer Therapeutics, 2007
- The Differential Effects of Mutant p53 Alleles on Advanced Murine Lung CancerCancer Research, 2005
- Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expressionOncogene, 2005
- Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni SyndromeCell, 2004
- Cell-cycle checkpoints and cancerNature, 2004
- Transactivation of the EGR1 Gene Contributes to Mutant p53 Gain of FunctionCancer Research, 2004
- Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutantsOncogene, 2003
- The p53 tumour suppressor geneNature, 1991
- Different Tumor-Derived p53 Mutants Exhibit Distinct Biological ActivitiesScience, 1990